Questions: Disease Burden Estimation and Comparative Health Assessment

Question 1

Disease A kills 100 people, each of whom would have lived 40 more years, and leaves no survivors with disability. Disease B kills no one but leaves 10,000 people with a condition weighted at 0.5 for 1 year each. Which disease has the higher DALY burden?

• A. Disease A, because mortality-based burden always outweighs morbidity-based burden
• B. Disease B, because its YLD total (5,000) exceeds Disease A's YLL total (4,000)
• C. They are equal — DALY calculations normalize across mortality and morbidity
• D. Disease A, because YLL counts full years lost while YLD is discounted by disability weight

Answer: (B)

Disease A: 100 deaths × 40 years = 4,000 YLL, 0 YLD → 4,000 DALYs. Disease B: 0 YLL + (10,000 × 0.5 × 1) = 5,000 YLD → 5,000 DALYs. Disease B has higher burden despite causing no deaths. This is precisely the point of the DALY framework: diseases that disable many people for long periods can impose greater total burden than diseases that cause fewer but more dramatic deaths. Option A reflects the common misconception that mortality is always the primary driver.

Question 2

The Global Burden of Disease study assigns disability weights through population surveys asking respondents to compare health states. What does this mean for the objectivity of DALY estimates?

• A. DALY estimates are objective because the surveys sample large populations across many countries
• B. Disability weights reflect value judgments about quality of life that vary culturally, so estimates carry embedded assumptions that may not transfer across populations
• C. Disability weights are objective because they measure functional impairment through clinical assessment
• D. The subjectivity is eliminated by using median responses from the survey population

Answer: (B)

Disability weights are not neutral biomedical measurements — they are derived from how survey respondents perceive the relative impact of different health states on quality of life. These perceptions vary across cultures, income levels, and lived experience of disability. A weight developed primarily from high-income country respondents may misrepresent the experience of the same condition in a low-income setting with different social support and expectations. This means DALY estimates are simultaneously real analytic tools and value-laden constructs.

Question 3

A disease can rank among the top global causes of DALY burden despite causing relatively few deaths, if it is highly prevalent and causes significant long-term functional impairment.

• T. True
• F. False

Answer: True

Depression is the canonical example: it causes relatively few deaths directly, but its high prevalence, chronic course, and substantial disability weight produce enormous YLD, placing it among the top global DALY burdens. The DALY framework was designed precisely to make this kind of comparison possible, correcting the bias of mortality-only metrics toward diseases that kill quickly.

Question 4

Disability weights used in DALY calculations are derived from biomedical measurements of functional loss, making them objective and culturally neutral.

• T. True
• F. False

Answer: False

Disability weights are derived from population surveys in which respondents compare health states and judge relative impacts on quality of life. These judgments are inherently value-laden and culturally variable — they reflect frameworks for evaluating disability, illness experience, and functional expectations that differ across societies. A weight derived from high-income country respondents may not accurately represent how the same condition is experienced or prioritized in other settings.

Question 5

Explain why two diseases with identical total DALY burdens might still receive very different levels of health investment in practice.

Model answer: Equal DALY burdens do not guarantee equal investment because allocation decisions depend on cost-effectiveness, political feasibility, equity considerations, and intervention availability. A disease with high burden but no affordable intervention may receive less funding than a lower-burden disease with a cheap, scalable cure. Equity concerns may also direct resources toward conditions affecting marginalized populations beyond what their absolute DALY share warrants.

Burden estimates inform but do not determine health policy. Disease burden is one input among several — others include cost per DALY averted, implementation feasibility, political will, and whether a disease disproportionately affects vulnerable groups. Pure burden-based priority-setting is an ideal that real policy processes always modify. Understanding this gap between burden metrics and actual investment is essential for anyone doing health systems work.